{
    "title": "EXPLAINER-Who can make Gilead's coronavirus drug, licence free?",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8292415/EXPLAINER-Who-make-Gileads-coronavirus-drug-licence-free.html",
    "date": "2020-05-06",
    "keywords": [
        "drug",
        "remdesivir",
        "treatment",
        "india",
        "world",
        "patent",
        "production",
        "firm",
        "trade",
        "wto",
        "agreement",
        "republic",
        "guinea",
        "pact",
        "licence",
        "need",
        "price",
        "gilead",
        "course",
        "inc",
        "chemical",
        "coronavirus",
        "europe",
        "asia",
        "company",
        "distribution",
        "organisation",
        "category",
        "httpswwwwtoorgenglishthewto_ewhatis_etif_eorg7_ehtm",
        "belong",
        "waiver",
        "property",
        "benin",
        "burkina",
        "faso",
        "burundi",
        "congo",
        "djibouti",
        "gambia",
        "bissau",
        "haiti",
        "lao",
        "lesotho",
        "liberia",
        "madagascar",
        "malawi",
        "mali",
        "mauritania",
        "mozambique",
        "myanmar",
        "niger",
        "rwanda",
        "sierra",
        "leone",
        "solomon",
        "togo",
        "httpswwwwtoorgenglishtratop_etrips_epharmpatent_ehtm",
        "ldcs",
        "compulsory",
        "invention",
        "consent",
        "holder",
        "export",
        "manufacturing",
        "infrastructure",
        "bangladeshs",
        "use",
        "government",
        "approval",
        "instance",
        "license",
        "drugmaker",
        "cancer",
        "medicine",
        "supplier",
        "blockbuster",
        "hepatitis",
        "sofosbuvir",
        "statement",
        "httpswwwgileadcomnewsandpresscompanystatementsgileadsciencesstatementonremdesivirglobalsupply",
        "pakistan",
        "indias",
        "part",
        "httpswwwgileadcommediafilespdfsotherhcv20generic20agreement20fast20facts20101615pdflaen",
        "cipla",
        "handful",
        "process",
        "time",
        "scale",
        "december",
        "industry",
        "vaccine",
        "virus",
        "institute",
        "review",
        "icer",
        "effectiveness",
        "cost",
        "beximco",
        "patient"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}